Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Mouridsen

Efficacy of First-Line Letrozole Versus Tamoxifen as a Function of Age in Postmenopausal Women With Advanced Breast Cancer

Oncologist

English

Related publications

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Journal of Clinical Oncology

English

Cost-Effectiveness of Palbociclib Plus Letrozole Versus Letrozole Alone as a First-Line Treatment in Women With Oestrogen Receptor-Positive, HER2-negative, Advanced Breast Cancer. Revised Results for the Swiss Health Care Setting

Breast Cancer Research and Treatment

Cancer Research

Oncology

2017

English

Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial

English

Effect of Anastrozole and Tamoxifen on Lipid Metabolism in Japanese Postmenopausal Women With Early Breast Cancer

English

Cognitive Function in Postmenopausal Breast Cancer Patients One Year After Completing Adjuvant Endocrine Therapy With Letrozole and/or Tamoxifen in the BIG 1-98 Trial

Breast Cancer Research and Treatment

Cancer Research

Oncology

2010

English

Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

English

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Journal of Clinical Oncology

English

Design, Conduct, and Analyses of Breast International Group (BIG) 1-98: A Randomized, Double-Blind, Phase-Iii Study Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Receptor-Positive, Early Breast Cancer

English

Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy

Oncology

Pharmacology

2016

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Mouridsen

Efficacy of First-Line Letrozole Versus Tamoxifen as a Function of Age in Postmenopausal Women With Advanced Breast Cancer

Related publications

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Cost-Effectiveness of Palbociclib Plus Letrozole Versus Letrozole Alone as a First-Line Treatment in Women With Oestrogen Receptor-Positive, HER2-negative, Advanced Breast Cancer. Revised Results for the Swiss Health Care Setting

Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial

Effect of Anastrozole and Tamoxifen on Lipid Metabolism in Japanese Postmenopausal Women With Early Breast Cancer

Cognitive Function in Postmenopausal Breast Cancer Patients One Year After Completing Adjuvant Endocrine Therapy With Letrozole and/or Tamoxifen in the BIG 1-98 Trial

Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Design, Conduct, and Analyses of Breast International Group (BIG) 1-98: A Randomized, Double-Blind, Phase-Iii Study Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Receptor-Positive, Early Breast Cancer

Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer